Varenicline implant (Shenzhen ScienCare Pharmaceutical)

N/A

Report date: 2023/08/28 17:54:16

Base Information

Drug NameVarenicline implant (Shenzhen ScienCare Pharmaceutical)
Drug Alias NameSK2109SK-2109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha-4/beta-2 agonists
TargetsNicotinic acetylcholine receptor alpha-4/beta-2
Therapy Area/IndicationsSmoking Cessation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShenzhen Sciencare Medical Industries Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Sciencare Medical Industries Co Ltd
Inactive CompaniesN/A
Active IndicationsSmoking Cessation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A